Eventide Asset Management - Q2 2024 holdings

$5.84 Billion is the total value of Eventide Asset Management's 161 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 20.4% .

 Value Shares↓ Weighting
TT BuyTRANE TECHNOLOGIES PLC$264,953,773
+10.0%
805,502
+0.4%
4.54%
+20.1%
TMDX SellTRANSMEDICS GROUP INC$172,524,667
+99.4%
1,145,430
-2.1%
2.95%
+117.8%
WCN BuyWASTE CONNECTIONS INC$141,531,127
+2.0%
807,089
+0.0%
2.42%
+11.4%
ROP BuyROPER TECHNOLOGIES INC$141,229,522
+1.4%
250,558
+0.9%
2.42%
+10.7%
ODFL BuyOLD DOMINION FREIGHT LINE IN$132,825,452
-19.1%
752,126
+0.4%
2.27%
-11.7%
DDOG BuyDATADOG INC$132,443,319
+5.4%
1,021,230
+0.5%
2.27%
+15.1%
TTD SellTHE TRADE DESK INC$127,304,543
-3.8%
1,303,415
-13.9%
2.18%
+5.0%
MIRM BuyMIRUM PHARMACEUTICALS INC$123,590,696
+49.1%
3,614,820
+9.5%
2.12%
+62.8%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$123,137,155
-5.9%
3,327,132
+6.7%
2.11%
+2.7%
DHI BuyD R HORTON INC$117,471,920
-9.4%
833,548
+5.8%
2.01%
-1.1%
GH SellGUARDANT HEALTH INC$108,604,337
+26.0%
3,760,538
-10.0%
1.86%
+37.5%
LRCX BuyLAM RESEARCH CORP$107,510,451
+16.9%
100,963
+6.7%
1.84%
+27.6%
MTD BuyMETTLER TOLEDO INTERNATIONAL$102,897,564
+5.4%
73,625
+0.4%
1.76%
+15.0%
CRWD BuyCROWDSTRIKE HLDGS INCcl a$95,777,574
+19.6%
249,948
+0.1%
1.64%
+30.5%
ARGX BuyARGENX SEsponsored adr$94,155,108
+9.3%
218,945
+0.0%
1.61%
+19.3%
IDXX SellIDEXX LABS INC$91,751,453
-23.8%
188,324
-15.5%
1.57%
-16.7%
POOL BuyPOOL CORP$88,227,374
-23.7%
287,077
+0.1%
1.51%
-16.8%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$84,835,923
-17.0%
2,634,656
+0.0%
1.45%
-9.4%
BuyTOAST INCcl a$83,378,294
+3.5%
3,235,479
+0.0%
1.43%
+12.9%
ROL BuyROLLINS INC$83,194,073
+33.7%
1,705,146
+26.8%
1.42%
+46.1%
MPWR BuyMONOLITHIC PWR SYS INC$81,020,113
+21.3%
98,603
+0.0%
1.39%
+32.5%
MNDY SellMONDAY COM LTD$76,782,457
-14.9%
318,917
-20.2%
1.31%
-7.1%
AXSM BuyAXSOME THERAPEUTICS INC$75,566,477
+173.1%
938,714
+170.7%
1.29%
+198.2%
PANW SellPALO ALTO NETWORKS INC$72,877,997
+19.1%
214,973
-0.1%
1.25%
+30.1%
EVH BuyEVOLENT HEALTH INCcl a$71,491,955
-17.5%
3,739,119
+41.5%
1.22%
-9.9%
XMTR BuyXOMETRY INC$69,597,755
-18.8%
6,020,567
+18.6%
1.19%
-11.4%
HUBS SellHUBSPOT INC$69,006,020
-22.2%
117,001
-17.4%
1.18%
-15.1%
TRGP BuyTARGA RES CORP$65,908,831
+24.7%
511,794
+8.4%
1.13%
+36.1%
LAD SellLITHIA MTRS INC$62,024,441
-25.5%
245,690
-11.2%
1.06%
-18.7%
ASML BuyASML HOLDING N V$61,480,391
+5.4%
60,114
+0.0%
1.05%
+15.1%
LOW BuyLOWES COS INC$60,210,272
-13.4%
273,112
+0.1%
1.03%
-5.4%
ENTG SellENTEGRIS INC$57,794,407
-16.8%
426,842
-13.6%
0.99%
-9.2%
PCVX BuyVAXCYTE INC$55,813,443
+24.3%
739,153
+12.5%
0.96%
+35.7%
NVT SellNVENT ELECTRIC PLC$55,208,077
-4.8%
720,638
-6.3%
0.94%
+4.0%
 LEXEO THERAPEUTICS INC$54,041,118
+2.3%
3,369,1470.0%0.92%
+11.7%
EXAS BuyEXACT SCIENCES CORP$52,040,508
-30.5%
1,231,728
+13.6%
0.89%
-24.2%
AJG BuyGALLAGHER ARTHUR J & CO$51,523,600
+32.0%
198,695
+27.2%
0.88%
+44.1%
FLYW SellFLYWIRE CORPORATION$50,357,144
-51.6%
3,072,431
-26.8%
0.86%
-47.2%
KLAC SellKLA CORP$50,109,595
+3.9%
60,775
-11.9%
0.86%
+13.5%
ARDX SellARDELYX INC$49,402,337
-0.7%
6,666,982
-2.1%
0.85%
+8.5%
BuyGITLAB INC$48,764,034
+20.2%
980,773
+41.0%
0.84%
+31.3%
TREX BuyTREX CO INC$48,676,531
-25.7%
656,726
+0.0%
0.83%
-18.9%
INSM BuyINSMED INC$45,237,395
+162.5%
675,185
+6.3%
0.77%
+186.7%
CDW BuyCDW CORP$45,212,099
-6.6%
201,984
+6.8%
0.77%
+2.0%
 AURA BIOSCIENCES INC$43,868,276
-3.7%
5,802,6820.0%0.75%
+5.2%
VST BuyVISTRA CORP$42,457,182
+63.5%
493,803
+32.4%
0.73%
+78.6%
FERG BuyFERGUSON PLC NEW$40,784,820
-3.0%
210,611
+9.4%
0.70%
+5.8%
CPRT BuyCOPART INC$38,646,085
-6.4%
713,554
+0.0%
0.66%
+2.2%
WMB BuyWILLIAMS COS INC$37,542,375
+36.2%
883,350
+24.9%
0.64%
+48.8%
NewNEXTRACKER INC$36,627,438781,302
+100.0%
0.63%
SRPT BuySAREPTA THERAPEUTICS INC$36,107,582
+105.9%
228,529
+68.7%
0.62%
+124.7%
SNPS SellSYNOPSYS INC$35,896,995
-10.6%
60,325
-14.1%
0.61%
-2.4%
GLBE SellGLOBAL E ONLINE LTD$35,646,301
-56.4%
982,804
-56.3%
0.61%
-52.4%
ORLY BuyOREILLY AUTOMOTIVE INC$35,368,505
-1.4%
33,491
+5.4%
0.60%
+7.7%
NTNX BuyNUTANIX INCcl a$35,261,440
+2664.0%
620,254
+2900.7%
0.60%
+2920.0%
ZNTL SellZENTALIS PHARMACEUTICALS INC$34,960,895
-80.8%
8,547,896
-26.2%
0.60%
-79.1%
ISRG BuyINTUITIVE SURGICAL INC$33,486,084
+11.5%
75,275
+0.1%
0.57%
+21.7%
CRNX SellCRINETICS PHARMACEUTICALS IN$32,924,592
-33.6%
735,088
-30.6%
0.56%
-27.5%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$32,539,902
-9.5%
2,897,587
+0.0%
0.56%
-1.2%
LSCC BuyLATTICE SEMICONDUCTOR CORP$32,294,515
-25.8%
556,898
+0.0%
0.55%
-19.0%
PWR NewQUANTA SVCS INC$31,991,710125,907
+100.0%
0.55%
HLI BuyHOULIHAN LOKEY INCcl a$31,675,917
+7.8%
234,880
+2.5%
0.54%
+17.6%
NARI SellINARI MED INC$29,836,099
-44.7%
619,649
-44.9%
0.51%
-39.6%
ALV SellAUTOLIV INC$29,794,147
-12.6%
278,476
-1.7%
0.51%
-4.7%
IRTC BuyIRHYTHM TECHNOLOGIES INC$29,287,983
+5.6%
272,092
+13.8%
0.50%
+15.2%
SHW BuySHERWIN WILLIAMS CO$29,199,883
-11.5%
97,845
+3.0%
0.50%
-3.3%
STE BuySTERIS PLC$29,000,575
+30.5%
132,097
+33.6%
0.50%
+42.1%
GERN NewGERON CORP$26,950,2126,356,182
+100.0%
0.46%
IRM BuyIRON MTN INC DEL$26,878,203
+35.3%
299,913
+21.1%
0.46%
+47.4%
EGP BuyEASTGROUP PPTYS INC$26,683,757
-1.3%
156,871
+4.3%
0.46%
+7.8%
FIVN SellFIVE9 INC$25,561,154
-41.6%
579,618
-17.8%
0.44%
-36.2%
SRRK BuySCHOLAR ROCK HLDG CORP$25,610,377
-4.7%
3,074,475
+103.2%
0.44%
+4.0%
DV SellDOUBLEVERIFY HLDGS INC$25,502,195
-69.1%
1,309,820
-44.2%
0.44%
-66.2%
RVMD BuyREVOLUTION MEDICINES INC$25,258,557
+117.1%
650,826
+80.3%
0.43%
+137.4%
CELC BuyCELCUITY INC$25,143,300
-16.3%
1,535,000
+10.4%
0.43%
-8.7%
KRYS  KRYSTAL BIOTECH INC$25,064,105
+3.2%
136,4850.0%0.43%
+12.6%
BPMC  BLUEPRINT MEDICINES CORP$24,971,009
+13.6%
231,6850.0%0.43%
+23.8%
AVB NewAVALONBAY CMNTYS INC$24,656,736119,178
+100.0%
0.42%
PNR BuyPENTAIR PLC$24,390,184
-9.9%
318,119
+0.4%
0.42%
-1.4%
NTAP BuyNETAPP INC$23,732,173
+114.3%
184,256
+74.6%
0.41%
+133.3%
VRSK BuyVERISK ANALYTICS INC$22,948,948
+64.9%
85,138
+44.2%
0.39%
+80.3%
KROS SellKEROS THERAPEUTICS INC$22,813,806
-49.3%
499,208
-26.6%
0.39%
-44.6%
SO BuySOUTHERN CO$22,604,906
+86.6%
291,413
+72.6%
0.39%
+103.7%
BuyBIOHAVEN LTD$22,029,187
+0.4%
634,664
+58.2%
0.38%
+9.6%
ESI BuyELEMENT SOLUTIONS INC$21,753,305
+18.0%
802,113
+8.7%
0.37%
+28.7%
WDAY BuyWORKDAY INCcl a$21,637,702
-16.1%
96,787
+2.4%
0.37%
-8.4%
UTHR NewUNITED THERAPEUTICS CORP DEL$21,605,65467,825
+100.0%
0.37%
ALNY  ALNYLAM PHARMACEUTICALS INC$21,141,000
+62.6%
87,0000.0%0.36%
+77.5%
PEG BuyPUBLIC SVC ENTERPRISE GRP IN$21,100,015
+36.4%
286,296
+23.6%
0.36%
+48.6%
NOVT BuyNOVANTA INC$20,617,756
-6.6%
126,404
+0.0%
0.35%
+2.0%
CERE  CEREVEL THERAPEUTICS HLDNG I$20,036,100
-3.3%
490,0000.0%0.34%
+5.5%
RPRX BuyROYALTY PHARMA PLC$19,767,743
-5.8%
749,630
+8.5%
0.34%
+2.7%
BuyMOBILEYE GLOBAL INC$18,912,608
-6.8%
673,406
+6.7%
0.32%
+1.9%
FDMT Buy4D MOLECULAR THERAPEUTICS IN$18,495,485
-25.2%
881,157
+13.5%
0.32%
-18.3%
BBIO  BRIDGEBIO PHARMA INC$18,159,761
-18.1%
716,9270.0%0.31%
-10.6%
SellKORRO BIO INC$17,922,480
-63.0%
529,155
-1.6%
0.31%
-59.6%
APTV BuyAPTIV PLC$17,659,998
-11.6%
250,781
+0.0%
0.30%
-3.5%
INZY BuyINOZYME PHARMA INC$17,555,541
-27.9%
3,936,220
+23.8%
0.30%
-21.2%
 R1 RCM INC$17,282,309
-2.5%
1,375,9800.0%0.30%
+6.5%
DYN NewDYNE THERAPEUTICS INC$17,115,650485,000
+100.0%
0.29%
INSP  INSPIRE MED SYS INC$16,740,795
-37.7%
125,0900.0%0.29%
-31.8%
RCKT BuyROCKET PHARMACEUTICALS INC$16,592,977
+25.5%
770,691
+57.0%
0.28%
+37.2%
MSCI SellMSCI INC$16,030,231
-63.9%
33,275
-58.0%
0.27%
-60.6%
AIT BuyAPPLIED INDL TECHNOLOGIES IN$15,615,642
+51.2%
80,493
+53.9%
0.27%
+64.8%
BuyREMITLY GLOBAL INC$15,357,434
-28.0%
1,267,115
+23.2%
0.26%
-21.5%
RNA NewAVIDITY BIOSCIENCES INC$15,356,495375,924
+100.0%
0.26%
RGEN  REPLIGEN CORP$15,001,140
-31.5%
119,0000.0%0.26%
-25.1%
IP NewINTERNATIONAL PAPER CO$14,644,981339,397
+100.0%
0.25%
ANAB BuyANAPTYSBIO INC$14,242,199
+48.1%
568,324
+33.1%
0.24%
+61.6%
KYMR BuyKYMERA THERAPEUTICS INC$13,793,655
+1635.2%
462,099
+2236.9%
0.24%
+1866.7%
CYTK  CYTOKINETICS INC$13,769,739
-22.7%
254,1480.0%0.24%
-15.4%
IEX BuyIDEX CORP$13,481,808
-17.2%
67,007
+0.5%
0.23%
-9.4%
VKTX  VIKING THERAPEUTICS INC$13,409,887
-35.4%
252,9690.0%0.23%
-29.2%
TGTX  TG THERAPEUTICS INC$12,787,701
+17.0%
718,8140.0%0.22%
+28.1%
FSLR NewFIRST SOLAR INC$12,490,25955,399
+100.0%
0.21%
VCYT  VERACYTE INC$12,221,880
-2.2%
564,0000.0%0.21%
+6.6%
GPI BuyGROUP 1 AUTOMOTIVE INC$12,214,641
+25.9%
41,088
+23.8%
0.21%
+37.5%
ARWR BuyARROWHEAD PHARMACEUTICALS IN$12,056,605
+34.6%
463,894
+48.1%
0.21%
+46.1%
COGT NewCOGENT BIOSCIENCES INC$11,793,5031,398,992
+100.0%
0.20%
IDYA  IDEAYA BIOSCIENCES INC$11,761,850
-20.0%
335,0000.0%0.20%
-13.0%
SellCONSTELLATION ENERGY CORP$11,142,222
-3.5%
55,636
-11.0%
0.19%
+5.5%
COG NewCOTERRA ENERGY INC$11,166,329418,685
+100.0%
0.19%
BuyGXO LOGISTICS INCORPORATED$11,152,117
-6.0%
220,834
+0.0%
0.19%
+2.7%
CBT BuyCABOT CORP$9,423,044
+0.0%
102,547
+0.4%
0.16%
+8.8%
NKTR NewNEKTAR THERAPEUTICS$9,336,0797,529,096
+100.0%
0.16%
RLI BuyRLI CORP$8,810,430
+70.2%
62,623
+79.6%
0.15%
+86.4%
SYY BuySYSCO CORP$8,623,127
-11.7%
120,789
+0.4%
0.15%
-3.3%
BRKR SellBRUKER CORP$8,410,924
-57.4%
131,812
-37.3%
0.14%
-53.5%
APLS  APELLIS PHARMACEUTICALS INC$8,047,698
-34.7%
209,7940.0%0.14%
-28.5%
FANG SellDIAMONDBACK ENERGY INC$7,641,252
-35.2%
38,170
-35.9%
0.13%
-29.2%
VRNA SellVERONA PHARMA PLCsponsored ads$7,631,713
-78.3%
527,781
-75.9%
0.13%
-76.3%
GKOS NewGLAUKOS CORP$7,520,19663,542
+100.0%
0.13%
CMS SellCMS ENERGY CORP$7,443,214
-26.9%
125,033
-25.9%
0.13%
-20.6%
SRE BuySEMPRA$5,999,309
+6.4%
78,876
+0.5%
0.10%
+17.0%
BuyLINDE PLC$5,874,788
+51.7%
13,388
+60.5%
0.10%
+65.6%
SNV SellSYNOVUS FINL CORP$5,480,188
-21.3%
136,357
-21.5%
0.09%
-13.8%
SPGI BuyS&P GLOBAL INC$4,978,252
+44.7%
11,162
+38.0%
0.08%
+57.4%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$4,301,624
+30.9%
24,749
+2.4%
0.07%
+42.3%
PNFP BuyPINNACLE FINL PARTNERS INC$3,630,294
-6.2%
45,356
+0.6%
0.06%
+1.6%
 VYNE THERAPEUTICS INC$3,130,2840.0%1,394,3360.0%0.05%
+10.2%
PCOR  PROCORE TECHNOLOGIES INC$3,163,120
-19.3%
47,7020.0%0.05%
-11.5%
OTIS BuyOTIS WORLDWIDE CORP$2,933,716
+190.0%
30,477
+199.1%
0.05%
+212.5%
EOG BuyEOG RES INC$2,681,786
+289.0%
21,306
+295.1%
0.05%
+318.2%
SellARTERIS INC$2,620,922
-10.3%
348,991
-12.5%
0.04%
-2.2%
 METAGENOMI INC$2,378,808
-61.3%
583,0410.0%0.04%
-57.3%
MDB SellMONGODB INCcl a$2,357,623
-95.4%
9,432
-93.4%
0.04%
-95.0%
INTU BuyINTUIT$2,351,497
+51.2%
3,578
+49.5%
0.04%
+66.7%
AMGN BuyAMGEN INC$2,239,954
+60.7%
7,169
+46.2%
0.04%
+72.7%
NVDA BuyNVIDIA CORPORATION$2,204,571
+71.2%
17,845
+1152.3%
0.04%
+90.0%
BuyNAYAX LTD$1,873,676
-18.3%
87,554
+0.4%
0.03%
-11.1%
HD NewHOME DEPOT INC$1,815,5225,274
+100.0%
0.03%
NOW BuySERVICENOW INC$1,667,740
+65.7%
2,120
+60.6%
0.03%
+81.2%
RSG NewREPUBLIC SVCS INC$1,581,1508,136
+100.0%
0.03%
UNP BuyUNION PAC CORP$1,501,688
+47.1%
6,637
+59.9%
0.03%
+62.5%
PRVA SellPRIVIA HEALTH GROUP INC$1,324,478
-93.2%
76,207
-92.4%
0.02%
-92.5%
NewMIRUM PHARMACEUTICALS INCnote 4.000% 5/0$1,277,156950,000
+100.0%
0.02%
 TURNSTONE BIOLOGICS CORP$1,200,7910.0%458,3170.0%0.02%
+10.5%
NewRAPPORT THERAPEUTICS INC$1,163,00050,000
+100.0%
0.02%
MU NewMICRON TECHNOLOGY INC$1,119,7158,513
+100.0%
0.02%
LLY BuyELI LILLY & CO$1,070,159
+57.4%
1,182
+35.2%
0.02%
+63.6%
FIVN  FIVE9 INCcall$2,240
-99.9%
32,0000.0%0.00%
-100.0%
WM ExitWASTE MGMT INC DEL$0-7,982
-100.0%
-0.03%
INTA ExitINTAPP INC$0-67,446
-100.0%
-0.04%
RCUS ExitARCUS BIOSCIENCES INC$0-240,000
-100.0%
-0.07%
ExitTOURMALINE BIO INC$0-320,916
-100.0%
-0.12%
EQIX ExitEQUINIX INC$0-12,357
-100.0%
-0.16%
MASS Exit908 DEVICES INC$0-1,430,995
-100.0%
-0.17%
AVTE ExitAEROVATE THERAPEUTICS INC$0-445,500
-100.0%
-0.21%
ALPN ExitALPINE IMMUNE SCIENCES INC$0-408,542
-100.0%
-0.25%
RARE ExitULTRAGENYX PHARMACEUTICAL IN$0-359,000
-100.0%
-0.26%
ExitMARINUS PHARMACEUTICALS INC$0-2,346,526
-100.0%
-0.33%
DLO ExitDLOCAL LTD$0-3,362,993
-100.0%
-0.78%
SPT ExitSPROUT SOCIAL INC$0-956,464
-100.0%
-0.90%
COUR ExitCOURSERA INC$0-4,515,809
-100.0%
-0.99%
SWAV ExitSHOCKWAVE MED INC$0-507,418
-100.0%
-2.59%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-08-13
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC43Q2 20243.2%
PALO ALTO NETWORKS INC43Q2 20243.6%
ASML HOLDINGS NV43Q2 20241.9%
REPLIGEN CORP43Q2 20240.5%
VERACYTE INC41Q2 20241.5%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
LAM RESEARCH CORP38Q2 20243.4%
COLLEGIUM PHARMACEUTICAL INC37Q2 20242.6%
BLUEPRINT MEDICINES CORP36Q2 20241.3%
XPO LOGISTICS INC34Q1 20233.8%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q2 2024 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
908 Devices Inc.February 14, 20241,430,9954.4%
Annexon, Inc.Sold outFebruary 14, 202400.0%
Celldex Therapeutics, Inc.February 14, 20243,630,0136.6%
COLLEGIUM PHARMACEUTICAL, INCFebruary 14, 20242,630,4788.1%
Freeline Therapeutics Holdings plcSold outFebruary 14, 202400.0%
Inozyme Pharma, Inc.February 14, 20243,179,8375.2%
Korro Bio, Inc.February 14, 2024546,3256.8%
MARINUS PHARMACEUTICALS, INC.February 14, 20244,529,9978.3%
Mirum Pharmaceuticals, Inc.February 14, 20242,693,5815.8%
Praxis Precision Medicines, Inc.Sold outFebruary 14, 202400.0%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-13
SC 13G/A2024-08-09
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings